APA

Wijnen J. P., Jiang L., Greenwood T. R., Cheng M., Döpkens M., Cao M. D., Bhujwalla Z. M., Krishnamachary B., Klomp D. W. J. & Glunde K. (20150204). Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS. : NMR in biomedicine.

Chicago

Wijnen J P, Jiang L, Greenwood T R, Cheng M, Döpkens M, Cao M D, Bhujwalla Z M, Krishnamachary B, Klomp D W J and Glunde K. 20150204. Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS. : NMR in biomedicine.

Harvard

Wijnen J. P., Jiang L., Greenwood T. R., Cheng M., Döpkens M., Cao M. D., Bhujwalla Z. M., Krishnamachary B., Klomp D. W. J. and Glunde K. (20150204). Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS. : NMR in biomedicine.

MLA

Wijnen J P, Jiang L, Greenwood T R, Cheng M, Döpkens M, Cao M D, Bhujwalla Z M, Krishnamachary B, Klomp D W J and Glunde K. Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS. : NMR in biomedicine. 20150204.